Purchases and Sales Made in Q4 2024 in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS) during Q4 2024. The information is specifically focused on institutions that hold shares of Aclaris Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
BUY
|
- |
212K+ 113.89% |
$243K - $971K
|
397K
$974K
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
610New |
$702 - $2.8K
|
610
$1.49K
|
|
Jan 14, 2025
Q4 2024
|
Marquette Asset Management, LLC
|
SELL
|
- |
-26.1K- 31.04% |
$30K - $120K
|
57.9K
$142K
|